(Q37406600)

20 August 2017

1 reference

title

Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease (English)

1 reference

20 August 2017

0 references

Fouad R Zakka

1

1 reference

20 August 2017

Peter Y Chang

series ordinal

2

1 reference

20 August 2017

Gian P Giuliari

series ordinal

3

1 reference

20 August 2017

C Stephen Foster

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

19 October 2009

1 reference

20 August 2017

Clinical Ophthalmology

1 reference

20 August 2017

3

1 reference

20 August 2017

567-579

1 reference

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Neovascularization of the optic disc in Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Pars plana vitrectomy for ocular complications of Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Current concepts in the etiology and treatment of Behçet disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Managing the symptoms of Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Medical treatment of cystoid macular edema

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Behçet's disease: a new target for anti-tumour necrosis factor treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Trabeculectomy with antiproliferative agents in uveitic glaucoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Thalidomide in Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Tacrolimus in dermatology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Cataract surgery in patients with Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Novel therapies in vasculitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Treatment of Behçet's disease--an update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Thalidomide: current and potential clinical applications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Anti-cytokine therapy for rheumatoid arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Selectin adhesion molecules in Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Behçet's disease in India: a clinical, immunological, immunogenetic and outcome study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Close association of HLA-Bw51 with Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Milestones in the treatment of gout

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Macula-sparing monocular blackouts. Clinical and pathologic investigations of intermittent choroidal vascular insufficiency in a case of periarteritis nodosa

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Treatment and visual prognosis in Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Behçet's disease. Report of 41 cases and a review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Toxicity of low dose methotrexate in rheumatoid arthritis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Therapy of Behçet's disease.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Determinants of serious liver disease among patients receiving low-dose methotrexate for rheumatoid arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Remission of Behçet's syndrome with tumour necrosis factor alpha blocking therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Immunotherapy for Behçet's disease

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Azathioprine in Behcet's syndrome: effects on long-term prognosis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Thalidomide neuropathy incidence and clinico-electrophysiologic findings in 42 patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

An HLA-D region restriction fragment associated with refractory Behçet's disease.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

The use of thalidomide in the management of bleeding from a gastric cancer

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Thalidomide for the treatment of severe intestinal bleeding

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

A pilot study of thalidomide in recurrent GI bleeding due to angiodysplasias

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Long-term efficacy and tolerance of tacrolimus for the treatment of uveitis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Long-term follow-up of tacrolimus treatment in immune posterior uveitis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Uveitis in Behçet disease: an analysis of 880 patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behçet's disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

BEHCET'S DISEASE; A REPORT OF 28 CASES.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

High dose methotrexate for ocular lesions of Behçet's disease. Preliminary short-term results.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Short-term chlorambucil for refractory uveitis in Behcet's disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Effect of infliximab on sight-threatening panuveitis in Behçet's disease.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Trabeculectomy and Molteno implantation for glaucomas associated with uveitis.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Trabeculectomy with mitomycin C in glaucoma associated with uveitis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Studies on the pharmacokinetics of chlorambucil and prednimustine in man.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS)

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2770868

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

5 November 2018

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity

1 reference

12 December 2020

Clinical Pharmacokinetics of Cyclophosphamide

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of uveitic macular edema

1 reference

12 December 2020

Treatment of Behçet's disease with thalidomide

1 reference

12 December 2020

Behçet's disease and treatment with colchicine

1 reference

12 December 2020

Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome

1 reference

12 December 2020

1 reference

12 December 2020

Leucocyte movement and colchicine treatment in Behcet's disease

1 reference

12 December 2020

The action of colchicine in acute gouty arthritis

1 reference

12 December 2020

Epidemiological features and visual prognosis of Behçet's disease

1 reference

12 December 2020

Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behçet disease

1 reference

12 December 2020

Management of uveitic glaucoma with Ahmed glaucoma valve implantation

1 reference

12 December 2020

Results of pars plana vitrectomy in Behçet's disease

1 reference

12 December 2020

Behçet's disease and complex aphthosis

1 reference

12 December 2020

Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity

1 reference

12 December 2020

The results of cataract extraction and intraocular lens implantation in patients with Behçet's disease

1 reference

12 December 2020

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects

1 reference

12 December 2020

Colchicine in Behçet's disease

1 reference

12 December 2020

[Behçet's disease. 316 cases]

1 reference

12 December 2020

Chlorambucil in steroid-dependent nephrotic syndrome

1 reference

12 December 2020

Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease

1 reference

12 December 2020

Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema

1 reference

12 December 2020

[Speculative ameloriation of arthritis in Behcet disease with thalidomide. A case report]

1 reference

12 December 2020

Pars plana vitrectomy in ocular Behçet's disease

1 reference

12 December 2020

Arthropathy of Behcet's disease with marked synovial pleocytosis responsive to colchicine

1 reference

12 December 2020

Effect of chlorambucil on spermatogenesis in the human with malignant lymphoma

1 reference

12 December 2020

A strong association between HLA-B*5101 and Behçet's disease in Greek patients

1 reference

12 December 2020

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

1 reference

12 December 2020

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

12 December 2020

[Posterior sub-Tenon's injections of repository corticosteroids in uveitis patients with cystoid macular edema]

1 reference

12 December 2020

Clinical pharmacokinetics of cyclophosphamide

1 reference

12 December 2020

Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma

1 reference

12 December 2020

Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçet's disease

1 reference

12 December 2020

Treatment of Behçet's disease with chlorambucil

1 reference

12 December 2020

Granulocytapheresis in patients with refractory ocular Behcet's disease

1 reference

12 December 2020

The role of azathioprine in the management of retinal vasculitis

1 reference

12 December 2020

[Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases]

1 reference

12 December 2020

Vitreoretinal surgery in Behçet's disease with severe ocular complications

1 reference

12 December 2020

Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine

1 reference

12 December 2020

Interferon-alpha 2b for refractory ocular Behçet's disease

1 reference

12 December 2020

Cataract surgery in patients with uveitis

1 reference

12 December 2020

Experience with photocoagulation in Behçet's disease

1 reference

12 December 2020

Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide

1 reference

12 December 2020

Successful treatment of Behçet disease with pentoxifylline

1 reference

12 December 2020

[Clinical and immunological studies on Behçet's syndrome]

1 reference

12 December 2020

Identifiers

1 reference

20 August 2017

1 reference